Considering the immunomodulatory and antioxidant effects of DPP4 inhibitors, whether DPP4 inhibitors can potentiate the anti-tumor effect of ICIs in NSCLC remains unclear. Here, DPP4 is linked to non-small cell lung carcinoma.